GlucoTrack
Rating
Key Statistics
Market Data
Valuation (TTM)
Valuation (NTM)
Cash Flow
Margins
Growth (CAGR)
Returns
Financial Health
Dividends
Profile
GlucoTrack, Inc. is a medical device company that focuses on the design, development, and commercialization of novel technologies for people with diabetes. The company is developing the GlucoTrack CBG...
Latest News
26 days ago · businesswire.com
Glucotrack, Inc. Announces Reverse Stock SplitRUTHERFORD, N.J. & LA JOLLA, Calif.--(BUSINESS WIRE)--Glucotrack Announce Reverse Stock Split.
2 months ago · gurufocus.com
Glucotrack, Inc. Announces Pricing of $3 Million Public OfferingGlucotrack, Inc. (NASDAQ: GCTK) (âGlucotrackâ or the âCompanyâ) today announced the pricing of a âbest effortsâ public offering of 169,388 shares of
2 months ago · benzinga.com
Why GlucoTrack Shares Are Trading Higher By Around 118%; Here Are 20 Stocks Moving PremarketShares of GlucoTrack Inc (NASDAQ:GCTK) rose sharply in pre-market trading following the announcement that its subsidiary, Lokahi Therapeutics, signed its first external, fee-for-service partnership.
2 months ago · businesswire.com
Lōkahi Therapeutics™ and Glucotrack CEO Erik Emerson Provides Strategic Update on LT-100, ai² Platform Growth and Clinical Development PrioritiesRUTHERFORD, N.J. & LA JOLLA, Calif.--(BUSINESS WIRE)--Lōkahi CEO Erik Emerson outlines LT-100 progress, ai² platform growth, and a strategy to discover, advance, and monetize assets.
2 months ago · gurufocus.com
Lōkahi Therapeutics™ Continues ai² Pipeline™ Division Collaboration with The University of Alabama to Advance Asset Evaluation and Biopharma TalentLÅkahi Therapeuticsâ¢, a subsidiary of Glucotrack, Inc. (Nasdaq: GCTK), today announced that The University of Alabama's Culverhouse College of Business will
2 months ago · gurufocus.com
Glucotrack Announces $11.5 Million FinancingGlucotrack, Inc. (NASDAQ: GCTK) (âGlucotrackâ or the âCompanyâ) today announced definitive agreements for convertible notes with an aggregate principal
3 months ago · businesswire.com
Glucotrack Achieves Key Compliance Milestone and Advances Strategic TransformationRUTHERFORD, N.J. & LA JOLLA, Calif.--(BUSINESS WIRE)--"We are approaching the months ahead with confidence, urgency, and a clear sense of purpose," said Erik Emerson, CEO of Glucotrack.
Add to Watchlist
Select watchlists to add or remove GCTK